September 3, 2021 06:02 AM EDTUpdated 03:41 PM

Ziopharm finds new CEO after six-month search; CFO transition at Lonza to take place in December

ENDPOINTS

Less than a year removed from a successful activist attack, Ziopharm Oncology appointed a new CEO this week. Taking the reins will be Kevin Boyle …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Ziopharm finds new CEO after six-month search; CFO transition at Lonza to take place in December

ENDPOINTS

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Zio­pharm finds new CEO af­ter six-month search; CFO tran­si­tion at Lon­za to take place in De­cem­ber

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Ziopharm finds new CEO after six-month search; CFO transition at Lonza to take place in December